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“HYPONATREMIA  AS  AN  INDEPENDENT  PREDICTOR  OF IN 
HOSPITAL   MORTALITY  IN PATIENTS  WITH SPONTANEOUS  
INTRACEREBRAL HEMORRHAGE” 
 
INTRODUCTION 
 
 
HEMORRHAGIC STROKE 
 
The word stroke is used to refer to a clinical syndrome, of presumed 
vascular origin, typified by rapidly developing signs of focal or global 
disturbance of cerebral functions lasting more than 24 hours or leading to 
death (World Health Organisation 1978). 
It affects between 174 and 216 people per 100,000 population in the UK 
each year (Mant et al 2004), and accounts for 11% of all deaths in England and 
Wales. Cerebral infarction accounts for 69% of strokes, primary haemorrhage 
for 13%, subarachnoid haemorrhage for 6%, and 12% are of uncertain type 
(Wolfe et al 2002). The risk of recurrent stroke within five years of a first 
stroke is between 30% and 43% (Mant et al 2004). 
Extravasation of blood into the brain parenchyma was recognized as 
early as 1658 by Wepfer, although he saw the clot as an obstruction of ‘vital 
spirits’ rather than as the disease in itself, and subsequently by Morgagni. The 
cause remained obscure, and to a large extent it still is. 
We have come a long way since the time when Charcot (1881) felt “that 
if apoplexy was not immediately fatal, most survivors only retained life at the 
expense of deplorable infirmities and perpetual confinement to bed.”  
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With the arrival of computed tomography of the brain, diagnosis of 
intra-cerebral haemorrhage has been taken from the age of calculated 
speculation with details of clinical features, angiograms and ‘bloody taps’ to 
the present day of arrival of a definitive diagnosis in a matter of minutes.  
 A significant reason for the decreasing trend of mortality in the intra-
cerebral haemorrhage patients in the industrialized countries have also been 
due to the identification of the factors which might adversely affect the 
outcome, stratifying patients and instituting prompt acute stroke care With the 
arrival of computed tomography of the brain, diagnosis of intra-cerebral 
haemorrhage has been taken from the age of calculated speculation with details 
of clinical features, angiograms and ‘bloody taps’ to the present day of arrival 
of a definitive diagnosis in a matter of minutes. A significant reason for the 
decreasing trend of mortality in the intra-cerebral haemorrhage patients in the 
industrialized countries have also been due to the identification of the factors 
which might adversely affect the outcome, stratifying patients and instituting 
prompt acute stroke care. 
Though medical management of intra-cerebral haemorrhage has been 
the way, surgical management has been known since the times of McEwen, 
who performed the first successful operation for intra-cerebral haematoma in 
1883. Though no definite guidelines exist to decide between the two lines of 
management, the increasing availability of minimally invasive techniques like 
stereo-tactic aspiration may make this modality indispensable in the days to 
come. 
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But all is not well for a country like India, where there still exist pockets 
where CT brain is unheard of, stroke care centers unimaginable, and supply 
almost always short of demand. Thereby, identifying definite risk factors, 
designing and implementing policies to contain them, making prompt and 
accurate diagnosis, stratifying patients according to outcome predictors, and 
thus ensuring prompt referral of deserving critical patients to tertiary centers 
for intensive management, may be the need of the hour.  
Intracerebral hemorrhage accounts for approximately 10% of strokes 
and its clinical importance derives from its frequency and accompanying high 
mortality. Although the latter is strongly dependent on HEMATOMA SIZE 
and to a lesser extent, LOCATION, the overall mortality rate varies between 
25% and 60%.There has been a general decline since the 1980s in the incidence 
of stroke, including ICH, as a result of improved detection and treatment of 
hypertension. However, ICH continues to be a major health problem especially 
in those who lack hypertension treatment and the genetically predisposed. 
A growing body of evidence suggests that genetic factors, such as the 
possession of the E2 and E4 alleles of the apolipoprotein E, play an important 
role in the occurrence of certain forms of ICH, such as lobar 
hemorrhages(O’Donnell et al., 2000). Novel potential genetic factors 
predisposing to ICH continue to be added by experimental and clinical studies 
( Gould et al., 2006). 
Although it would appear intuitively that evacuation of a hematoma 
might be beneficial, surgical results have not been superior to those with 
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medical measures alone (Waga and Yamamoto; Batjer et al; Juvela et al; 
Rabinstein et al). 
A large, multicenter, randomized study involving 1,033 patients with 
supratentorial hemorrhage, under the auspices of the Surgical Trial in 
Intracerebral Haemorrhage (STICH) study reported by Mendelow and 
colleagues, has failed to show a benefit from early surgery on survival or 
neurologic functioning at 6 months. This negative result extended to almost all 
levels of neurologic deficit and all age groups. In a post hoc analysis, clots that 
were small and close to the surface of the brain may have benefited from 
evacuation. 
As a result, this approach has been virtually abandoned, but in a few 
instances with on going deterioration in young patients with hematomas that 
are easily accessible from the cortical surface, evacuation of the clot has been 
undertaken. In contrast, the surgical evacuation of cerebellar hematomas is a 
generally accepted treatment and is a more urgent matter because of the 
proximity of the mass to the brainstem and the risk of abrupt progression to 
coma and respiratory failure. 
Mayer and coworkers studied the promising approach of administering 
clotting factor VII within 4 h of hemorrhage. In a preliminary study(phase 
I&II), survival was improved and there was a reduction in enlargement of the 
hematoma, but their subsequent series(phase III FAST trial) has failed to 
confirm the benefit on survival so that infusion of factor VII is not currently 
part of routine practice.Therefore, the surgical management of ICH is debatable 
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because the assessment of potential interventions awaits the completion of 
properly designed prospective clinical trials. 
HYPONATREMIA 
Hyponatremia is the most common electrolyte abnormality seen in 
hospitalised patients and is also the most common electrolyte imbalance seen 
in critically ill neurologic patients. It can significantly alter the morbidity, 
short and long term mortality of the underlying disease. 
There are different types of hyponatremia based on the volume status of 
the individual.  
They are  
1. Euvolemic hyponatremia  
2. Hypervolemic hyponatremia  
3. Hypovolemic hyponatremia  
Particularly in hospital setting with acute medical problems, the recognition of 
different types of hyponatremia and appropriate clinical intervention is critical 
for improving patient outcomes. Data regarding the prevalence and different 
types of hyponatremia in elderly in our country is limited.  
History and clinical examination including  assessment of volume status, 
measuring serum osmolality, serum sodium and urinary sodium concentrations 
is essential to differentiate the types of hyponatremia and to detect the possible 
etiological factor responsible for hyponatremia and to determine the most 
appropriate treatment.  
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The causes of hyponatremia are varied, but in neurologically ill 
patients, are most commonly attributed to Syndrome of Inappropriate Anti-
diuresis and Cerebral Salt Wasting. Both these entities are cerebral in origin 
but have distinct pathophysiology, prognosis and treatment options.. 
SIADH is a subclinically volume expanded state due to inappropriate 
anti-diuresis. This causes excessive volume overload over the body sodium 
content leading onto euvolemic hyponatremia. In stroke SIADH occurs due to 
AVP secretion inappropriate to the osmotic threshold.  
The suppressed proximal renal tubular transport in this condition can 
lead on to bicarbonaturia and hypouricemia. The effective treatment is fluid 
restriction. Hypertonic saline therapy is reserved for cases of severe 
hyponatremia. 
CSW, on the other hand, is essentially a volume depleted state, which 
occurs due to the combined effects of decreased sympathetic outflow and 
increased natriuretic peptides. This resultant natriuresis leads to volume 
depletion and an appropriate AVP response. So the treatment for CSW 
includes an aggressive volume replacement regimen with isotonic saline or in 
severe cases, hypertonic saline. Thus most CSW patients meet the criteria for 
SIADH and have elevated AVP levels but worsen with the treatment protocol 
given for SIADH. 
This observation lead to the description of CSW as a separate entity 
and widespread studies were carried out to distinguish the two entities 
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Hyponatremia, especially Cerebral Salt Wasting, occurring in the setting 
of stroke has been shown to worsen the prognosis of stroke, increase morbidity, 
short and long term mortality, and causes poorer discharge disposition. 
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OBJECTIVES OF OUR STUDY 
To investigate the prevalence of hyponatremia, its associations with 
clinical characteristics, its influence on mortality and functional outcome in 
patients with spontaneous intracerebral hemorrhage. 
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MATERIALS AND METHODS: 
SOURCE OF STUDY: 
Data consists of primary data collected by the principal investigator directly 
from the cases of Spontaneous intracerebral hemorrhage admitted in the 
medical ward in Coimbatore Medical College Hospital. 
DESIGN OF STUDY: 
 Cross sectional study 
PERIOD OF STUDY: 
ONE YEAR 
METHODOLOGY: 
This is a cross sectional study of 100 cases managed for Spontaneous 
intracerebral hemorrhage in the medical ward of Coimbatore Medical College 
Hospital.All the test  done with due permission from the Institutional Ethical 
Committee and informed consent from the subjects. 
Selection Criteria 
Inclusion criteria  
1) All pts above age 18 yrs. & radiologically proven, diagnosed cases of 
spontaneous intracerebral hemorrhage. 
Exclusion criteria  
1)  Pts below 18.  
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2) ICH Secondary to anticoagulation (INR >1.4) 
3) ICH Secondary to trauma,tumour,arteriovenous  malformations.  
4) ICH occurring after acute thrombolysis  
5)  ICH in patients with platelet count <50,000/mcl 
6) Patients with ICH and received the mannitol or hypertonic saline 
infusion before reaching our hospital. 
7) patients on diuretics treatment  
PROCEDURE: 
After getting permission from  IRB, patients was selected after explaining 
the purpose of study & procedure in detail and  getting their informed 
consent in written format.  
A complete physical examination and necessary investigations was done to 
confirm the diagnosis. 
DATA MANAGEMENT AND ANALYSIS: 
The data obtained were analyzed using SPSS version 21.0 software. Results 
were expressed in frequencies and percentages. 
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REVIEW OF LITERATURE: 
BLOOD SUPPLY OF BRAIN: 
 The brain receives blood from two sources: the internal carotid arteries, which 
arise at the point in the neck where the common carotid arteries bifurcate, and 
the vertebral arteries . 
 The internal carotid arteries branch to form, the anterior and middle cerebral 
arteries. 
 The right and left vertebral arteries come together at the level of the pons on 
the ventral surface of the brainstem to form the midline basilar artery 
 The basilar artery joins the blood supply from the internal carotids in an arterial 
ring at the base of the brain (in the vicinity of the hypothalamus and cerebral 
peduncles) called the circle of Willis. 
 The posterior cerebral arteries arise at this confluence, as do two small bridging 
arteries, the anterior and posterior communicating arteries. 
 The major branches that arise from the internal carotid artery—the anterior and 
middle cerebral arteries—form the anterior circulation that supplies the 
forebrain 
 Each gives rise to branches that supply the cortex and branches that penetrate 
the basal surface of the brain, supplying deep structures such as the basal 
ganglia, thalamus, and internal capsule 
 Particularly prominent are the lenticulostriate arteries that branch from the 
middle cerebral artery 
 These arteries supply the basal ganglia and thalamus 
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Figure.1  Circle of willis and blood supply of blood supply of brain along 
the inferior surface of brain : 
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Blood supply of medial surface of brain: 
 
 
Figure.2  Blood supply of medial surface of brain: 
Blood supply of lateral surface of brain: 
 
Figure.3  Blood supply of lateral surface of brain 
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 INTRACEREBRAL HAEMORRHAGE 
Intracerebral haemorrhage accounts for 10 to 15% of first time strokes 
all over the world1. Incidences are predicted to be higher in Asian population2. 
The 30 day mortality ranges from 32% to 55 %2. Of the total patients with ICH, 
only 20 % of patients are expected to be functionally independent at the end of 
6 months2. 
 
Figure.4  Intra Cerebral Hemorrhage 
PRIMARY (HYPERTENSIVE) INTRACEREBRAL HEMORRHAGE 
This is the mundane but often a devastating "spontaneous" brain 
hemorrhage. It is predominantly a result of chronic hypertension and 
degenerative changes in cerebral arteries. In order of frequency, the most 
common sites of a cerebral hemorrhage are 
 (1) the putamen and adjacent internal capsule (50%);  
(2) the central white matter of the temporal, parietal, or frontal lobes 
(lobar hemorrhages, are not strictly associated with hypertension);                                               
(3) the thalamus;  
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(4) one or the other cerebellar hemisphere; and 
(5) the pons. 
 The vessel involved is usually a small penetrating artery that originates 
from a larger trunk vessel. Approximately 2 percent of primary hemorrhages 
are multiple. Multiple nearly simultaneously intracerebral hemorrhages raise 
the possibility of amyloid angiopathy or a bleeding diathesis but may occur 
when one conventional hypertensive intracerebral hemorrhage causes 
hypertension, which in turn leads to one or more additional hemorrhages3. 
The extravasation of blood into the substance of the brain forms a 
roughly circular to oval mass that disrupts the tissue and can grow in volume if 
the bleeding continues .Adjacent brain tissue is distorted and compressed. If the 
hemorrhage is large, midline structures are displaced to the opposite side of the 
cranium and the reticular activating and respiratory centers are compromised, 
leading to coma and death.  
It has been known that both the size and the location of the clot 
determine the degree of secondary brainstem compression and this was 
prooved by Andrew and associates. Rupture or seepage of blood into the 
ventricular system or rarely to the surface of the subarachnoid space  CSF 
becomes bloody in these cases. When the hemorrhage is small and located at a 
distance from the ventricles, the CSF may remain clear even on repeated 
examinations. In the first hours and days following the hemorrhage, varying 
degrees of edema accumulates around the clot adding to the mass effect. 
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Hydrocephalus may occur as a result of bleeding into the ventricular 
system or from compression of the third ventricle. This extravasated blood 
undergoes a predictable series of changes.  
At first, the fluid collection becomes a clot within hours. Before the clot 
forms, red cells settle in the dependent part of the hematoma and forms a 
meniscus with the plasma above; this is particularly prone to occur in cases of 
anticoagulant-induced hemorrhage. 
 The resultant fluid level can be observed on CT scan and MRI 
("hematocrit effect"). Hematomas, when examined in autopsy material, 
contains only masses of red blood cells and proteins. The hematoma is often 
surrounded by small to large petechial hemorrhages from torn arterioles and 
venules. 
Within a few days onwards, hemoglobin products degrades into 
hemosiderin and hematoidin, begin to appear. The hemosiderin formed within 
histiocytes have phagocytized red blood cells (RBCs) and takes the form of 
ferritin granules that stain positively for iron. Oxyhemoglobin liberated from 
the RBCs becomes deoxygenated and forms methemoglobin. This imparts a 
brownish hue to the periphery of the clot. Phagocytosis of red cells occrs within 
24 h, and hemosiderin is first observed around the margins of clot around 5 to 6 
days.  
The clot changes colour gradually over a few weeks from dark red to 
pale red, and the border of golden-brown hemosiderin widens. The edema 
disappears takes days to weeks to disappear. In 2 to 3 months, larger clots are 
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filled with a chrome-coloured thick fluid, which is slowly absorbed, leaving a 
yellow-brown scar. The iron pigment (hematin) becomes dispersed and studs to 
adjacent astrocytes and neurons and may persist beyond the border of the 
hemorrhage for years3. 
Imaging techniques shows a predictable sequence of changes. Initially in 
CT scans, fresh blood is visualized as a white mass. The mass effect and the 
surrounding  edema are hypodense. After 2 to 3 weeks, the surrounding edema 
begins to recede and the density of the hematoma decreases  first at the 
periphery. Gradually the clot becomes isodense with brain. There may be a ring 
of enhancement from the hemosiderin-filled macrophages and the reacting cells 
that form a capsule for the hemorrhage. 
After several weeks the bleed may transiently simulate a tumor or 
abscess. By MRI, T1- or T2-weighted images, the hemorrhage is not easily 
visible in the 2 or 3 days after bleeding, as oxyhemoglobin is diamagnetic or, 
slightly hypointense, so that only the mass effect is evident. MR gradient-echo 
images  will show hemorrhages earlier and remnants of deposited hemosiderin 
even years afterwards3. 
After several days the surrounding edema is hyperintense in T2-
weighted images. As deoxyhemoglobin and methemoglobin forms, the 
hematoma signal becomes bright on T1-weighted images and dark on T2. As 
the hematoma once  becomes subacute, the dark images gradually brighten. 
When methemoglobin disappears and hemosiderin remains, the entire 
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remaining mass is hypodense on T2-weighted images, as are the surrounding 
deposits of iron.  
The sizes of cerebral hemorrhages vary widely. Massive refers to 
hemorrhages several centimeters in diameter; small applies to those 1 to 2 cm 
in diameter and less than 20 mL in volume. The volume and location  predicts 
outcome and the nature of the neurologic deficits3. 
Figure.5  EXPANSION OF ICH SIZE IN RESPECT WITH 
 
TIME DURATION 
 
 
 
 
 
 
 
 
 
 
 
HOURS FROM ONSET 
 
Risk Factors 
There has been a rapid and remarkable 60% decline in death rates from 
stroke  in most of the industrialized countries since 19725.In addition, there is a 
striking decline in the incidence of intra-cerebral haemorrhage in Sweden8. 
12-24 0-3 6-12   3-6 
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This declining trend in case fatality rate of stroke in most  industrialized 
countries may be explained by 3 mechanisms. 
1. Improved acute stroke care which has prolonged survival. 
2. Stroke cases in these places are less severe 
3. Stroke cases that were mild in severity and previously undetected are being 
detected now9. 
This data highlights  the operation of environmental influences that are 
amenable to modification, and the intensity of effort and optimal utilization of 
public health resources to implement preventive measures  for developing 
countries like India to deal with stroke. Untreated or under-treated 
hypertension is the single most important risk factor for spontaneous 
intracerebral haemorrhage (ICH)3. 
Spontaneous intracerebral haemorrhage is considered to be a direct 
effect of chronic hypertension and the degenerative changes in the cerebral 
arteries3 Advanced age and heavy alcohol consumption are also known to be 
risk factors for ICH2. 
Pathogenesis 
Sustained hypertension induces smooth muscle cell proliferation in the 
arterioles termed as hyperplastic arteriolosclerosis42. Over time, smooth muscle 
cells die and the tunica media is replaced by collagen, resulting in vessels with 
decreased tone and poor compliance. The arterioles undergo ectasia and 
aneurysmal dilation42. These micro aneurysm  called Charcot-Bouchard 
aneurysms  are susceptible to rupture result in cerebral hemorrhage and were 
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proposed by Charcot and Bouchard in 1868 as a key element of deep 
ICH43,44,45. These aneurysms, occur in vessels that are less than 300 micro 
meter in diameter, most commonly in the basal ganglia, thereby making this the 
most common location of bleed4. However in few of the haemorrhages 
examined at autopsy with serial sections by C M fisher, the bleeding could not 
be traced to the a forementioned aneurysms3. 
Takebayaschi and co workers, in an electron microscopy study, found 
breaks in the elastic lamina at multiple sites, almost always at the bifurcation of 
the small vessels. These sites represent secondary rupture from tearing of small 
vessels by the expanding hematoma3. The extravasated blood that disrupts and 
compresses the adjacent tissue as it grows in volume. 
Large  hemorrhage can displace  midline structure  to the opposite side  
that results in compromised  reticular activating and respiratory centers ,leading 
to coma and death. 
In the first few hours to days following the haemorrhage, a limited 
amount of oedema accumulates around the clot that adds to the mass effect. 
Hydrocephalus may occur as a result of bleeding into the ventricular system or 
from compression of the third ventricle3. 
Clinical features 
Of all the cerebrovascular diseases, brain hemorrhage is the most 
dramatic and has been given its own name, "apoplexy." The prototype is an 
obese, plethoric, hypertensive male who falls senseless to the ground— 
impervious to shouts, shaking, and pinching—breathes stertorously, and dies in 
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a few hours. A massive blood clot escapes from the brain as it is removed 
postmortem. With smaller hemorrhages, the clinical picture conforms more 
closely to the usual temporal profile of a stroke, i.e., an abrupt onset of 
symptoms that evolve gradually and steadily over minutes or hours, depending 
on the size of the ruptured artery and expansion of bleeding3. 
Perihematomal   edema volume increases by approximately 75%-80% 
during the first 24 hours after spontaneous ICH and it has been implicated in 
the delayed mass effect  that  occurs  in the second and third weeks  after  
ICH55, 56. 
The clinical presentation of ICH had two main elements:   
1. Symptoms that  reflect  the  effects of  intracranial  hypertension and 
2. Those that are specific for the location of the haematoma. 
The clinical features related to ICP are headache,vomiting,depressed  level of 
consciousness, which vary in their frequency93. 
A few clinical  features  with intra-cerebral  haemorrhage  need special 
mention.Acute reactive hypertension, far exceeding the patient’s   chronic  
hypertensive  level, isa feature that should always suggest  haemorrhage; it is 
seen with moderate and large clots situated in deep regions. Vomiting  occurs 
much more frequently with hemorrhage than infarction. 
Severe headache is generally considered to be an imminent symptom 
of intra-cerebral haemorrhage, but in almost 50 percent of cases headache has 
been absent or mild in degree.Loss of consciousness is more often a feature of 
haemorrhage than ischemic stroke. 
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patients are alert at presentation. Seizures usually focal, occur in the first few 
days in some 10 to 15 percent of cases of supratentorial haemorrhage, but more 
commonly as a delayed event, months or even years after the event. 
Most  of  the haemorrhages develop over 30 – 90 minutes2. Thereby the 
patient might develop headache or vomiting, followed by sagging of the face in 
the next few minutes, followed by slurring of speech and then notice the arms 
and legs gradually weakening3. However, haemorrhages may occur when the 
patient is calm and unstressed (Caplan, 1993).Headache, acute hypertension, 
and vomiting with a focal neurologic deficit are therefore the cardinal features  
serve  to distinguish haemorrhage from ischemic stroke. Having  said that, it 
must be noted that these prodromal symptoms do not occur with any 
consistency3.           
Types of intracerebral haemorrhage: 
Putaminal haemorrhage 
This is the most common site of hypertensive bleed, and the adjacent  
internal  capsule is usually damaged. Contralateral  hemiparesis is therefore  
the  sentinel sign. When haemorrhage is large it results in drowsiness  to coma, 
a dilated pupil and fixed  ipsilateral  pupil, and decerebrate rigidity. 
Thalamic haemorrhages 
They produce a contralateral hemiparesis due to extension into the 
adjacent internal capsule. A prominent sensory deficit involving all the sensory 
modalities is usually present. Thalamic haemorrhage, by virtue of its extension 
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into the subthalamus and high midbrain, may cause  a  series of ocular 
disturbances. 
Figure.6   Sites of spontaneous intracerebral hemorrhage 
   
Pontine haemorrhages 
 Pontine hemoorhage ensues deep coma within few mintes, and the 
clinical picture is dominated by total paralysis, decerebrate rigidity, and 
pinpoint pupils that react to light. Lateral eye movements, evoked by head 
turning or caloric testing, are impaired or absent. Death usually occurs within a 
few hours. 
Cerebellar Haemorrhage 
Repeated vomiting is a prominent feature, along with occipital 
headache,vertigo, and gait disturbance. In the early phase of the illness,other 
clinical signs of cerebellar disease may be minimal or lacking; only a minority 
of cases show nystagmus or cerebellar ataxia of the limbs, although these signs 
must always be sought. Dysarthria and dysphagia may be prominent in some 
cases but usually absent. In  the  series collected  by  St. Louis and colleagues, 
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patients with vermian clots and hydrocephalus were at the highest risk for rapid 
deterioration. As the hours pass, and occasionally with unanticipated 
suddenness, the patient becomes stuporous and then comatose or suddenly 
apneic as a result of brainstem compression, at which point reversal of the 
syndrome, even by surgical therapy, is seldom successful3. 
Caudate haemorrhage: 
The most common clinical presentations are severe headache, nausea, 
vomiting, and signs of marked meningeal irritation, mimicking a SAH or 
primary IVH. These patients show no prominent motor, sensory, or visual 
abnormalities (Pedrazzi et al 1990).The parenchymal haematoma itself does not 
require surgical intervention but emergency extraventricular drainage may be 
required when acute hydrocephalus develops. However, a permanent VP Shunt 
is necessary only rarely76.                                                                                     
Lobar Hemorrhage: 
Bleeding especifically in the subcortical white matter of one of the lobes 
of the cerebral hemisphere, is not associated strictly with hypertension. Any 
number of other causes are usually responsible, the main ones being 
anticoagulation or thrombolytic therapy, acquired coagulopathies, cranial 
trauma, arteriovenous malformation, trauma, and, in the elderly, amyloidosis of 
the cerebral vessels.In one series of 26 patients with lobar ICH, 14 had normal 
blood pressure, and in several of the fatal cases there was amyloidosis of the 
affected vessels; 2 patients were receiving anticoagulants, 2 had an 
arteriovenous malformation, and 1 had a metastatic tumor. Similarly, in the 
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series of 22 patients with lobar clots reported by Kase and colleagues, 55 
percent were normotensive; metastatic tumors, arteriovenous malformations, 
and blood dyscrasias were found in 14, 9, and 5 percent of the patients, 
respectively. Amyloid angiopathy is an important cause of lobar hemorrhage in 
the elderly patients 
Course and Prognosis; 
The immediate prognosis for large and medium-sized cerebral clots is 
grave; some 30 to 35 percent of patients die in 1 to 30 days. In these cases, 
either the hemorrhage has extended into the ventricular system or intracranial 
pressure becomes elevated to levels that preclude normal perfusion of the brain. 
Or the hemorrhage seeps into vital centers such as the hypothalamus or 
midbrain3. 
A formula that predicts outcome of hemorrhage based on clot size was 
devised by Broderick and co workers; it is mainly applicable to putaminal and 
thalamic clots.  
A volume of 30 mL or less, calculated by various methods from the CT 
scan predicted a generally favorable outcome; only 1 of their 71 patients with 
clots larger than 30 mL had regained independent function by 1 month. By 
contrast, in patients with clots of 60 mL or larger and an initial Glasgow Coma 
Scale score of 8 or less, the mortality was 90 percent . 
As remarked earlier, it is the location of the hematoma, not simply its 
size that determines the clinical effects. A clot 60 mL in volume is almost 
uniformly fatal if situated in the basal ganglia but may allow reasonably good 
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outcome if located in the frontal or occipital lobe. From the studies of Diringer 
and colleagues (1998), hydrocephalus is also an important predictor of poor 
outcome3. 
Predictors of Outcome 
Intra-cerebral haemorrhage has been known as the stroke subtype with 
the highest case fatality rates from time immemorial7.To identify the patients 
with a potential worse outcome would enable the treating team to anticipate 
and triage patients for stratifying care and prognosticate for the sake of clinical 
research and explaining the situation to the family. Numerous parameters have 
been identified, some with consistent results in predicting outcomes, and others 
not so. 
Age 
Age has been reported to be a significant independent outcome predictor 
in some 13,14 but not the majority of previous studies. Age may appear 
important for several reasons.  
Younger patients tend to present to hospital sooner after ictus13; 
although no specific therapy has been demonstrated to have a significant effect 
on outcome in controlled trials, earlier treatment may reduce mortality. 
Second, the elderly, may not receive life-sustaining treatment as 
aggressive as that 
given to younger patients. Finally, age may serve as a proxy for other inter-
current illnesses that might complicate the clinical situation. 
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Glasgow Coma Scale 
The Glasgow Coma Scale (GCS) measures the best eye, motor and 
verbal responses, and is a widely used and accepted prognostic score for both 
traumatic and non-traumatic altered consciousness levels18. The score has been 
validated for its inter-observer reliability19. 
The assessment of consciousness level in acute stroke is important for 
clinical management and as an indicator of prognosis. As stroke may cause 
localized motor,speech or language deficits, the accuracy of the GCS as a 
measure of consciousness level may be affected. In turn, its’ prognostic value 
may be impaired. 
Weir et al found that dysphasic subgroup showed that the verbal 
component provided additional prognostic information to the combined eye 
and motor scores17. When a language disorder is absent, the verbal score 
contributes prognostic information by measuring level of consciousness or by 
acting as a marker for confusion17. Thereby, the GCS score might retain 
independent outcome predictor value in stroke patients, its utility is increased if 
combined with the other stroke predictors17. 
The National Institutes of Health Stroke Scale (NIHSS) 
The NIHSS is a 15-item neurologic examination stroke scale used to 
evaluate the effect of acute stroke on the levels of consciousness, language, 
neglect, visual-field loss, extraocular movement, motor strength, ataxia, 
dysarthria, and sensory loss and thereby quantitate accurately the neurological 
deficit. 
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There is an allowance for untestable items 28. The scale is widely used as 
a clinical assessment tool to evaluate acuity of stroke patients, determine 
appropriate treatment, and predict patient outcome29. 
Computed tomography findings 
With the advent of CT scanning, estimations of the volume of intra-
cerebral haemorrhages were possible which lead to numerous studies, which 
confirmed a positive correlation between increasing volume of bleed and 
worsening outcome22,27. Kothari et al then went to on devise a simple technique 
to estimate the volume of bleed by using the formula for volume estimation of 
an ellipsoid24. The volume as estimated by the above technique has been 
validated to be accurate and quick to use23. Expansion of the haematoma as a 
complication has been noted to have a graver prognosis25. 
Tuhrim S et al noted that intra-ventricular extension of a bleed in a 
supra-tentorial location was associated with worsening of prognosis27. This 
finding was confirmed by a few other studies as an independent predictor of 
outcome15. 
Infra-tentorial location of the bleed has been identified as a potential 
predictor of poor outcome, due to the increased chances of obstructive 
hydrocephalus and brainstem involvement17, 26. 
Outcome predictor scores 
Most of these independent variables which predicted outcome in ICH 
patients were noted to have greater significance of correlation on combination 
as assessed by multivariate analysis.One of the earliest and one that has stood 
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the test of time is the Intra-Cerebral Haemorrhage(ICH) score as conceived 
by J Claude Hemophill et al15. 
 Based on the strength of independent association of the specified 
parameters, points were assigned and a stratification scale designed. The total 
ICH Score ranges from 0 to 5 and the 30 day mortality of each of the scores 
was found to have a linear correlation with the score15. 
Figure 7.  ICH Score 
ICH volume 
 
> 30cc 1 
< 30cc  0 
Intraventricular extension 
 
Yes 1 
No 0 
Infratentorial location 
 
Yes 1 
No 0 
Age 
 
> 80 1 
< 80 0 
Glasgow coma scale 
 
3-4 
5-12 
13-15 
2 
1 
0 
Total score 0-6 
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HYPONATREMIA 
  The consequences of salt depletion was first described by Mc Cance in 
1936 [1]. 
In 1950, Peters et al [2] at Yale described three neurologic patients with 
hyponatremia. Both patients had increased urine sodium loss and dehydration 
in spite of high sodium diet. In 1952, Cort [3] in Yale described another similar 
patient as having Cerebral salt wasting syndrome. 
In1953,Leaf et al[4] demonstrated that giving exogenous vasopressin 
caused hyponatremia and natriuresis. He described this to be a physiologic 
response to increased intra-vascular volume. 
Schwartzet al [5] published the paper on SIADH which became a 
milestone. For over two decades the term CSW vanished from literature. In 
1981,Nelson et al [6] reintroduced the term . 
Further correlations between hyponatremia in subarachnoid 
haemorrhage with increased levels of natriuretic peptides, negative sodium 
balance,[7], [8] and low central venouspressure[9] were published in many studies. 
SODIUM AND WATER REGULATION 
The interactions among kidney and the brain play an important role in 
the sodium and water homeostasis. 
 Arginine vasopressin or the Anti-diuretic hormone,the key hormone is 
synthesised in a precursor form in the magnocellular neurons of the supra-optic 
and paraventricular nuclei in the hypothalamus. From the hypothalamus it is 
transported by axonal transport to the neurohypophysis ,cleaved to the active 
form and secreted into the blood. 
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Disorders of sodium balance are due to disorders in regulation of water 
balance. Defects in water intake and Arginine vasopressin levels are the major 
effectors of plasma osmolality. This would in turn affect the sodium levels. 
HYPONATREMIA 
Hyponatremia is the most common electrolyte disturbance in neurologic 
patients [10]Hyponatremia is defined as sodium level of less than < 130 meq/L 
and occurs in 20% of hospitalised patients [11] and the in-hospital mortality rate 
is found to be 1.8 fold higher than those with normal sodium levels [12]. 
Water and sodium homeostasis are tightly regulated and thus 
disturbances in water homeostasis can lead onto sodium imbalance. 
Sodium being the major extracellular ion is the principal determinant of 
serum osmolality. Thus interplay between circulating vasopressin and water 
intake plays a key role in regulating the serum osmolality. Relative sodium 
concentration thus changes with water homeostasis and hence absolute plasma 
sodium values do not suffice to tell about the volume status of the patient. 
Hyponatremia is a very common disorder occurring in upto 22% of inpatients. 
The main mechanisms responsible include 
1.Increase in circulating Vasopressin 
2.Increased renal sensitivity to AVP 
3.Low solute intake 
Based on the underlying pathophysiology, hyponatremia may be Euvolemic, 
Hypovolemic or Hypervolemic 
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HYPOVOLEMIC HYPONATREMIA 
Hypovolemia 
Neurohumoral activation 
Increased circulating Vasopressin level 
1.V1A receptor mediated blood pressure maintenance 
2.V2 receptor mediated free water reabsorption 
Hypovolemic hyponatremia may be caused through 
1.Renal losses like RTA, diuretic usage, ketonuria, osmotic dieresis and 
rarely cerebral salt wasting syndrome.In renal losses, there is excessive loss of 
solute from the body and hence an appropriate rise of circulating AVP occurs. 
Salt losing nephropathies typically lead to hyponatremia in the setting of a 
reduced sodium intake. Causes of salt losing nephropathies include reflux 
nephropathy, medullary cystic disease, post-obstructive uropathy and the 
recovery phase in Acute Tubular Necrosis. 
   Thiazide diuretics cause not only diuretic induced volume depletion 
but can also cause polydipsia. Increased excretion of an osmotically active 
agent like ketonuria, glycosuria, mannitol administration and bicarbonaturia. 
2.Non- renal losses like third space fluid loss like pancreatitis, GI losses 
like vomiting or diarrhoea, insensible loss like burns 
In renal losses, urinary sodium measures > 20 mM whereas in non renal 
losses the urinary sodium tends to remain < 20 mM. 
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HYPERVOLEMIC HYPONATREMIA 
This is characterised by an increased total body sodium content and an 
inappropriately greater increase in the total body water. The different causative 
mechanisms can be differentiated by the urinary sodium concentration with 
acute or chronic renal failure causing increased urinary sodium, cirrhosis, 
cardiac failure causing decreased urinary sodium excretion. The degree of 
hyponatremia serves as an indirect measure of the degree of neuro-humoral 
activation and serves as an important prognostic factor. 
EUVOLEMIC HYPONATREMIA 
Conditions leading onto increased total body water in the setting of a 
normal sodium concentration result in euvolemic hyponatremia. 
Causes of euvolemic hyponatremia: 
1.Moderate to severe hypothyroidism  
2.Pituitary disease causing secondary adrenal insufficiency due to a 
predominant glucocorticoid deficient state. In contrast, primary adrenal 
insufficiency, leads on to hypovolemic hyponatremia. 
  Glucocorticoids exert a negative feedback on vasopressin release in 
such an effective manner, that hydrocortisone replacement can rapidly 
normalise the circulating AVP, correcting the sodium imbalance. 
3.The Syndrome of Inappropriate Anti-diuresis is the most frequent 
cause of euvolemic hyponatremia. In SIADH the osmotic threshold and the 
osmotic response curves are shifted downward. The precipitation of 
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hyponatremia is by excessive free water intake at serum osmotic values lesser 
than the normal threshold. 
Four distinct patterns of SIADH are known to occur 
1. Unregulated erratic AVP secretion- seen in one-third of the patients, 
where the AVP secretion does not correlate with the serum osmolality. 
2. Failure of suppression of AVP secretion at lower serum osmolalities 
with a normal response to hyperosmolar conditions. 
3. Resetting of the osmostat – causing lowering of the osmotic threshold 
and left shift of the osmotic response curve. 
4. Gain in function of renal water reabsorption or a circulating anti-diuretic 
substance apart from vasopressin. A gain of function mutation of the V2 
AVP receptor in the collecting tubule could lead to constitutive 
activation of the V2 AVP receptor even in the absence of AVP and 
hence leads on to Nephrogenic SIADH. 
SIADH patients are not euvolemic but have a subclinically expanded body 
volume. This volume expansion is due to vasopressin mediated water and 
sodium chloride retention. In SIADH, there is increased distal sodium and 
water transport and this leads to a supressed proximal tubular reabsorption and 
thus leading to low serum uric acid levels (<4 mg/dl), in contrast in patients 
with hypovolemic hyponatremia, there is hyperuricemia due to shared 
activation of proximal tubule sodium-chloride and urate transport.SIADH is 
caused by a variety of diseases, the common causes of which include 
pneumonia, tuberculosis, pleural effusion, tumor, subarachnoid haemorrhage, 
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meningitis. It can also occur as a para-neoplastic condition as in small cell 
carcinoma of the lung, attributing to 75% of the malignancy associated SIADH. 
Upto 10% of the patients with this tumor are found to have sodium levels of< 
130mM during initial presentation. 
SIADH is also frequently caused by drugs like Selective Serotonin 
Reuptake Inhibitors. 
Other drugs can cause SIADH by causing enhanced sensitivity to the 
circulating vasopressin, and they include 
Chlorpropamide 
Tricyclic antidepressants 
Clofibrate 
Carbamazepine 
Vincristine 
Nicotine 
Narcotics 
Ifosfamide 
MDMA- can cause acute hyponatremia 
Desmopressin 
Oxytocin 
Vasopressin 
Hyponatremia due to low solute intake- 
Commonly seen due to beer potomania, beer having a low salt and protein 
content (1-2mM of sodium) and excessive beer intake can caue hyponatremia. 
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It has also been described in people eating extreme vegetarian diets and 
other nutrient restricted diets. 
These patients typically present with a very low urine osmolality (< 100-
200 mOsm/kg) and a urine sodium of < 10-20 mM. The reduced urinary 
sodium excretion will also limit water excretion thus causing volume expansion 
and thus hyponatremia occurs in the setting of modest polydipsia. Resumption 
of a normal diet rich in solute or saline hydration would correct the 
hypovolemia due to low solute intake. 
CLINICAL FEATURES OF HYPONATREMIA 
Hyponatremia 
Water movement ECF       ICF 
Generalised cellular swelling 
cerebral Edema 
Neurologic Symptoms 
 ACUTE HYPONATREMIA 
Increased interstitial pressure 
Shunting of water and solutes into CSF 
Shunting into systemic Circulation 
Efflux of Na+, K+ and Cl- from brain cells 
Hyponatremic encephalopathy 
Acute hyponatremia is a medical emergency and can result in normocapneic or 
hypercapneic respiratory failure, seizures, brain stem herniation, coma and 
death. 
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CAUSES OF ACUTE HYPONATREMIA 
Iatrogenic- post operative 
Hypotonic fluid therapy causing increased AVP 
Glycine irrigation- during TURP/ Uterine surgery 
Colonoscopy Preparation 
Recent thiazide use 
Polydipsia 
MDMA intake 
Exercise 
Multifactorial causes 
CHRONIC HYPONATREMIA 
Chronic persistent hyponatremia 
Efflux of organic osmolytes from brain cells 
Decreased intracellular osmolality 
Water influx down the osmotic gradient into the cells Chronic 
hyponatremia can still result in some amount of nausea, vomiting, confusion, 
and seizures especially when levels fall below 125mM 
At times the patient may manifest only with subtle gait defects, 
increased fall risk and cognitive defects that are reversible with sodium 
correction.During correction of hyponatremia, the the re-accumulation of the 
brain osmolytes as the osmolality rises is delayed and this could result in 
degeneration of oligodendrocytes and hence demyelination.  
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This is especially marked during rapid correction and there is also a 
disruption of the blood brain barrier and entry of immune mediators, 
contributing to the demyelination.  
The classical region affected is pons where the re-accumulation of 
osmolytes is markedly delayed. Clinically, the patients may present after 1 or 
more days with paraparesis, quadriparesis, ‘locked-in syndrome’ or coma. 
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Approach to a neurologic patient with hyponatremia 
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Figure 8. THE GENERAL APPROACH TO THE HYPONATREMIC 
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PATIENT       
Abbreviations: ECF, extracellular fluid volume; EABV, effective arterial 
blood volume. 
Hyponatremia in the setting of central nervous system diseases occur 
commonly in two patterns- 
1.Syndrome of Inappropriate Anti- Diuretic Hormone secretion and 
2.Cerebral Salt Wasting due to interaction between the brain and kidneys [21] 
SYNDROME OF INAPPROPRIATE ANTI-DIURETIC HORMONE 
SECRETION 
SIADH is a volume-expanded state 
In SIADH, there is 
1.Inappropriate increase in ADH secretion which leads to an increased EABV. 
2.downward resetting of the osmotic thirst threshold leading on to a volume 
expanded state. 
As shown by studies of exogenous pitressin administration [4] to normal 
population, excess of vasopressin increases water retention and thus leads to an 
abrupt decrease in urine volume and increased urine osmolality, and leads to an 
increase in body weight and hyponatremia. 
After several days, a steady state is reached and sodium excretion 
becomes equal to dietary sodium intake. This is attributed to the vasopressin 
escape phenomenon [22] causing decreased proximal sodium reabsorption. 
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During this steady state, large isotonic sodium load could lead to a 
quantitatively similar urinaryexcretion of sodium. [23] This shows that a normal 
renal handling in spite of decreased serum sodium is a characteristic in SIADH. 
In SIADH, ECF expansion is not accompanied by overt signs of 
hypervolemia like neck vein distension or peripheral edema, but has increased 
GFR and increased renal blood  
flow. Due to decreased proximal tubular reabsorption, uric acid and urea, both 
of which are proximally reabsorbed, are also seen to decrease in blood [24]. 
 
  ESSENTIAL FEATURE(DIAGNOSTIC CRITERIA FOR SIADH)[25] 
 
 Decreased effective osmolality (<275 mOsm/kg of water) 
 
 Urinary osmolality >100 mOsm/kg of water during hypotonicity 
 
 Clinical euvolemia 
 
 No clinical signs of volume depletion of extracellular fluid 
 
 No orthostasis, tachycardia, decreased skin turgor, or dry mucous membranes. 
 No clinical signs of excessive volume of extracellular fluid No edema or 
ascites 
 
 Urinary sodium >20 mEq/L with normal dietary salt intake 
 
 Normal thyroid and adrenal function 
 
 No recent use of diuretic agents 
 
 Plasma uric acid <4 mg/Dl 
 
 Blood urea nitrogen <10 mg/dL 
 
 Fractional sodium excretion >1%; fractional urea excretion >55% 
 
 Failure to correct hyponatremia after 0.9% saline infusion 
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 Correction of hyponatremia through fluid restriction Abnormal result on test 
of water load (<80% excretion of 20 mL of water per kilogram of body 
weight over a period of 4 hours), or inadequate urinary dilution (<100 
mOsm/kg of water) 
 
 Elevated plasma AVP levels, despite the presence of hypotonicity and clinical 
euvolemia 
 
   
Encephalitis (viral or bacterial) Cavernous sinus thrombosis 
Meningitis (viral, bacterial, 
tuberculosis, fungal) 
Neonatal hypoxia 
Traumatic brain injury Hydrocephalus 
Brain abscess Delirium tremens 
Brain tumors Cerebrovascular accident 
Guillain-Barré syndrome Acute psychosis 
Acute intermittent porphyria Peripheral neuropathy 
Subarachnoid haemorrhage Multiple sclerosis 
Subdural hematoma Any kind of surgery, most notably 
Cerebellar and cerebral atrophy transsphenoidal pituitary surgery 
  
 
Figure 9- NEUROLOGIC DISEASES COMMONLY ASSOCIATED 
WITH SIADH 
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CEREBRAL SALT WASTING 
The recognition of a distinct subset of hyponatremic patients having 
hypovolemia in spite of meeting the criteria of SIADH, lead to the discovery of 
Cerebral Salt Wasting. Wijdicks et al. [26] showed the development of a 
condition similar to SIADH in SAH patients but had a 10% decrease in plasma 
volume. He also found that a negative sodium balance preceeded the condition. 
 Levine et al. [27] showed hyponatremia and volume depletion in ten 
craniosynostosis post- operative patients in spite of intravenous fluid 
administration to match sodium output. 
CSW is a volume-depleted state hypothesised to be due to decreased 
sympathetic nervous system outflow in patients with a CNS insult. Also shown 
to be implicated are increased levels of natriuretic factors like atrial natriuretic 
peptide and brain natriuretic peptide.  
PATHOPHYSIOLOGY OF CSW 
Decreased sympathetic input to the kidney causes 
1. Alteration in the sodium and water handling of the proximal tubule 
2. Failure of rise in renin and aldosterone levels in response to 
hyponatremia[ 28, 29] 
Increased natriuretic peptides can 
1. Increase GFR by dilatation of afferent and constriction of efferent renal 
arterioles. 
2. Cause direct inhibition of sodium reabsorption from inner medullary 
cortical duct [30] 
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3. Direct inhibition of renin release in the juxta glomerular apparatus. 
4. Inhibition of aldosterone release from the adrenal glands. 
5. Decrease sympathetic outflow from the brain stem. 
Increased natriuretic peptides especially BNP has been proved by 
Berendes et al [29].Patients with SAH who underwent aneurysmal clipping were 
compared with controls of patients undergoing craniotomy for brain tumor 
resection. After a three to four day duration, the SAH group had a peak increase 
of urine sodium excretion and correlated with increased BNP levels. The BNP 
levels also correlated with intracranial pressure and with the level of urine 
sodium excretion.The volume depletion in CSW activates baroreceptors 
thereby stimulating increased Anti-diuretic hormone secretion and hence 
patients with CSW also show increased ADH levels.The incidence is found to 
be 34% in aneurysmal SAH patients [13] and 70% in tuberculous meningitis [14] 
and 35.3% in stroke[15] and 25-35% after trans sphenoidal surgeries [16, 17]                                                        
DIFFERENCES BETWEEN SIADH AND CSW 
 
Differentiating between the two entities is of utmost importance due to 
the varied prognostic and treatment options between them.Differentiation can 
be difficult due to an overlap of laboratory parameters between the two 
entities.The primary difference lies in the effective arterial blood volume 
(EABV), which is increased in SIADH and vice versa in CSW. Since EABV is 
a clinical entity it can only be indirectly measured by levels of urine sodium 
excretion and ECF volume. Thus the differentiation of SIADH and CSW 
requires a panel of physical and laboratory investigations. 
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Physical features: 
 
SIADH shows features of normal to increased ECF volume whereas  CSW 
shows dry  skin and  mucosa , orthostasis, flat neck veins, and a negative fluid 
balance [11] 
 
 CSW SIADH 
Extracellular fluid volumeb Decreased Increased 
Hematocrit Increased Normal 
Plasma albumin concentration Increased Normal 
Plasma BUN/creatinine Increased Decreased 
Plasma Kþ Normal or increased Normal 
Plasma uric acid Decreased Decreased 
Treatment Normal saline Fluid restriction 
 
Figure 10. DIFFERENTIATION BETWEEN SIADH AND CSW [11] 
 
Determination of extracellular fluid volume is the primary way to 
differentiate CSW from SIADH.Serum uric acid is a special tool in SIADH and 
CSW differentiation. It initially tends to be low in both [31, 32], being 
inappropriately low in CSW.                       39 
On correction of sodium levels, it tends to normalise in SIADH whereas 
it remains abnormally low in CSW patients [31] due probably to prolonged 
proximal tubule dysfunction [31,33]. 
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TREATMENT OF SIADH vs CSW 
The treatment modalities widely vary for SIADH and CSW and it is 
important to distinguish between the two since inappropriate treatment can 
result in an adverse outcome. 
In CSW, fluid restriction can worsen the already volume depleted state and can 
worsen the underlying neurologic problem.Wijdicks et al. [34] showed the 
development of delayed cerebral infarction in 21 on 44 SAH patients who were 
treated with fluid restriction though 15 of these patients satisfied SIADH 
criteria. This was later attributed to possible CSW. The decreased plasma 
volume in conjunction with the vasospasm in SAH could have been the 
causative of delayed cerebral infarction. 
Thus in CSW aggressive salt and fluid replacement is necessary to 
maintain intravascular volume.Intravenous saline (isotonic or hypertonic), salt 
tablets or agent with mineralocorticoid activity like fluodrocortisone are the 
various treatment options [35, 36] 
On the other hand, SIADH requires fluid restriction as the treatment 
.Intravenous  saline  given in this volume-expanded state could lead to 
symptomatic hyponatremia, and worsening  clinical condition.So the 
osmolality of the administered fluid should exceed the osmolality of urine 
[11].More targeted therapies would include AVP receptor antagonists [37]The 
other  treatment options would include drugs like frusemide, demeclocycline 
and lithium. 
Patients with acute sodium reductions and severe neurologic symptoms 
may need initial rapid sodium correction with hypertonic saline, but caution is 
necessary to prevent against osmotic demyelination during correction [38,39] 
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RESULTS AND OBSERVATIONS 
AGE 
Mean (SD) age of the participants was 64.5 (13.4) years 
 
Table-2.1 Association of Age with Hyponatremia (N=100) 
Group 
Age in Years 
Mean Difference P value* 
Mean SD 
HN 63.3 2 
2.1 0.43 
No HN 65.4 1.8 
 
Independent t test was used 
 
Figure 2.1.Association of Age with Hyponatremia 
 
Statistical analysis of AGE association with Hyponatremia in ICH is NOT 
SIGNIFICANT 
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GENDER 
Table-2.2 Distribution of Gender (N=100) 
 
Sex Number Percentage 
Male 64 64 
Female 36 36 
Total 100 100 
 
 
 
Figure 2.2. Distribution of Gender 
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Table-2.3 Association of Gender with Hyponatremia (N=100) 
 
Sex 
Hyponatremia 
P value* 
HN No HN 
Male 30 (46.9) 34(53.1) 
0.29 
Female 13(36.1) 23(63.9) 
*Chi-squared test was used 
 
Figure 2.3 - Association of gender with Hyponatremia 
 
Statistical analysis of GENDER association with Hyponatremia in ICH is 
NOT SIGNIFICANT 
                                                                                                                                                   
50 
 
SYSTOLIC BLOOD PRESSURE 
 
Table-2.4 Association of SBP with Hyponatremia (N=100) 
 
Group 
SBP 
Mean Difference P value* 
Mean SD 
HN 168.8 24.1 
10.8 0.027 
No HN 158.1 23.3 
*Independent t test was used 
    
 
Figure 2.4- Association of SBP with Hyponatremia 
 
Statistical analysis of association of SYSTOLIC BLOOD PRESSURE with  
Hyponatremia in ICH is SIGNIFICANT 
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DIASTOLIC BLOOD PRESSURE 
Table-2.5 Association of DBP with Hyponatremia (N=100) 
 
Group 
DBP Mean 
Difference 
P value* 
Mean SD 
HN 100.7 10.6 
4.6 0.03 
No HN 96.1 9.9 
 
*Independent t test was used 
 
 
Figure 2.5- Association of DBP with Hyponatremia 
 
Statistical analysis of association of DIASTOLIC BLOOD PRESSURE with 
 Hyponatremia in ICH is SIGNIFICANT 
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GCS SCORE 
Table-2.6 Association of GCS with Hyponatremia (N=100) 
Group 
GCS0 
Mean Difference P value* 
Mean SD 
HN 11.3 1.9 
0.45 0.29 
No HN 11.7 2.4 
*Independent t test was used 
 
 
Figure 2.6- Association of GCS with Hyponatremia 
 
Statistical analysis of association of GCS SCORE with hyponatremia in ICH is  
NOT SIGNIFICANT 
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RANDOM BLOOD SUGAR 
Table-2.7 -Distribution of RBS on Admission (N=100) 
 
RBS on admission Number Percentage 
70 to 100 16 16 
100 TO 140 36 36 
140 TO 200 32 32 
Above 200 16 16 
Total 100 100 
  
 
 
 
Figure 2.7- Distribution of RBS on Admission 
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Table-2.8 Association of RBS on admission with Hyponatremia (N=100) 
 
RBS on admission N 
Hyponatremia 
P value* 
HN No HN 
70 to 100 16 6 (37.5) 10 (62.5) 
0.29 
100 to 140 36 16 (44.4) 20 (55.6) 
140 to 2000 32 17 (53.1) 15 (46.9) 
Above 200 16 4 (25) 12 (75) 
*Chi-squared test was used 
 
 
Figure 2.8- Association of RBS on admission with Hyponatremia 
 
Statistical analysis of association of RBS with Hyponatremia in ICH is NOT 
SIGNIFICANT 
 
55 
 
COMORBIDITIES 
Table-2.9 Distribution of Comorbidity (N=100) 
 
Comorbidity Number Percentage 
None 21 21 
SHT 23 23 
DM 26 26 
Both 30 30 
Total 100 100 
 
 
 
 
Figure 2.9 Distribution of Comorbidity 
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Table-2.10 Association of comorbidities with Hyponatremia (N=100) 
 
Comorbidities N 
Hyponatremia 
P value* 
HN No HN 
None 21 6 (28.6) 15 (71.4) 
0.335 
SHT 23 12 (52.2) 11 (47.8) 
DM 26 10 (38.5) 16 (61.5) 
Both 30 15 (50) 15 (50) 
*Chi-squared test was used 
 
 
Figure 2.10-Association of comorbidities with Hyponatremia 
 
Statistical analysis of association of COMORBIDITIES with Hyponatremia in 
ICH is NOT SIGNIFICANT 
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SERUM OSMOLALITY 
Table-2.11 Distribution of Serum Osmolality (N=100) 
 
Serum osmolality Number Percentage 
Normal 67 67 
Decreased 33 33 
Total 100 100 
 
 
 
Figure 2.11-Distribution of Serum Osmolality 
 
58 
 
Table-2.12 Association of Serum Osmolality with Hyponatremia (N=100) 
 
Serum Osmolality N 
Hyponatremia 
P value* 
HN No HN 
Normal 67 10 (14.9) 57 (85.1) 
<0.001 
Decreased 33 33 (100) 0 
*Fisher’s Exact Test was used 
 
 
Figure 2.12-Association of Serum Osmolality with Hyponatremia 
 
Statistical analysis of association of SERUM OSMOLALITY with 
Hyponatremia in ICH is SIGNIFICANT 
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URINE OSMOLALITY 
Table-2.13 Distribution of Urine Osmolality (N=100) 
 
Urine Osmolality Number Percentage 
Normal 58 58 
Decreased 9 9 
Increased 33 33 
Total 100 100 
 
 
 
 
Figure 2.13- Distribution of urine osmolality 
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Table-2.14 Association of Urine Osmolality with Hyponatremia (N=100) 
 
Urine Osmolality N 
Hyponatremia 
P value* 
HN No HN 
Normal 58 8 (13.8) 50 (86.2) 
<0.001 Decreased 9 2 (22.2) 7 (77.8) 
Increased 33 33 (100) 0 
*Fisher’s Exact Test was used 
 
 
Figure 2.14-Association of Urine Osmolality with Hyponatremia 
 
Statistical analysis of association of URINE OSMOLALITY with 
Hyponatremia in ICH is SIGNIFICANT 
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URINE SODIUM EXCRETION 
Table-2.15 Distribution of urinary sodium excretion (N=100) 
 
Urinary Sodium Excretion Number Percentage 
Normal 58 58 
Decreased 9 9 
Increased 33 33 
Total 100 100 
 
 
 
 
Figure 2.15- Distribution of urinary sodium excretion 
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Table-2.16 Association of Urinary Sodium Excretion with Hyponatremia 
(N=100) 
 
Urinary Sodium 
Excretion 
N 
Hyponatremia 
P value* 
HN No HN 
Normal 58 8 (13.8) 50 (86.2) 
<0.001 Decreased 9 2 (22.2) 7 (77.8) 
Increased 33 33 (100) 0 
*Chi-squared test was used 
 
 
 
Figure 2.16-Association of Urinary Sodium Excretion with Hyponatremia 
 
Statistical analysis of association of URINARY SODIUM EXCRETION with 
Hyponatremia in ICH is SIGNIFICANT 
63 
 
ECG: 
Table-2.17 Distribution of ECG findings (N=100) 
 
ECG findings Number Percentage 
Normal 79 79 
Hypertensive 21 21 
Total 100 100 
 
 
 
 
 
 
 
 
 
 
Figure 2.17-Distribution of ECG findings 
 
 
 
 
 
64 
 
 
Table-2.18 Association of ECG Findings with Hyponatremia (N=100) 
 
ECG N 
Hyponatremia 
P value* 
HN No HN 
Normal 79 31 (39.2) 48 (60.8) 
0.14 
Hypertensive 21 12 (54.1) 9 (42.9) 
 
*Chi-squared test was used 
 
 
 
Figure 2.18 -Association of ECG Findings with Hyponatremia 
 
Statistical analysis of association of ECG CHANGES with Hyponatremia in 
ICH is  NOT SIGNIFICANT 
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CT BRAIN 
Table-2.19 Distribution of CT brain (N=100) 
 
MRI Brain Number Percentage 
Lobar Hemorrhage 27 27 
Infratentorial Hemorrhage 40 40 
Intracerebral Hemorrhage with Midline Shift 23 23 
Intracerebral Hemorrhage with 
Intraventricular Extension 
10 10 
Total 100 100 
 
 
 
Figure 2.19- Distribution of CT brain  
 
 
Intracerebral  
Hemorrhage 
Infratentorial 
Hemorrhage 
66 
 
 
Table-2.20 Association of CT Brain Findings with Hyponatremia (N=100) 
 
CT Brain 
TOTAL 
Hyponatremia 
P value* 
HN No HN 
Lobar Hemorrhage 27 14 (51.9) 13 (48.2) 
0.238 
Infratentorial Hemorrhage 41 13 (31.7) 28 (68.3) 
Intracerebral Hemorrhage with 
Midline Shift 
22 10 (45.5) 12 (54.6) 
Intracerebral Hemorrhage with 
Intraventricular Extension 
10 6 (60) 4 (40) 
*Chi-squared test was used 
 
Figure 2.20 Association of CT Brain Findings with Hyponatremia 
 
Statistical analysis of association of CT BRAIN FINDINGS with hyponatremia 
in ICH is  NOT SIGNIFICANT 
Infratentorial 
Hemorrhage 
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MRI BRAIN 
Table-2.21 Distribution of MRI brain  (N=100) 
 
MRI Brain Number Percentage 
Lobar Hemorrhage 27 27 
Infratentorial Hemorrhage 40 40 
Intracerebral Hemorrhage with Midline Shift 23 23 
Intracerebral Hemorrhage with 
Intraventricular Extension 
10 10 
Total 100 100 
 
 
 
Figure  2.21 Distribution of MRI brain 
 
 
 
Infratentorial 
Hemorrhage 
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Table-2.22 Association of MRI Brain Findings with Hyponatremia 
(N=100) 
MRI Brain N 
Hyponatremia 
P value* 
HN No HN 
Lobar Hemorrhage 27 14 (51.9) 13 (48.2) 
0.238 
Infratentorial Hemorrhage 40 13 (32.5) 27 (67.5) 
Intracerebral Hemorrhage with 
Midline Shift 
23 10 (43.5) 13 (56.5) 
Intracerebral Hemorrhage with 
Intraventricular Extension 
10 6 (60) 4 (40) 
*Chi-squared test was used 
 
 
Figure  2.22 Association of MRI Brain Findings with Hyponatremia 
 
Statistical analysis of association of MRI BRAIN FINDINGS with 
Hyponatremia in ICH is  NOT SIGNIFICANT 
Infratentorial  
Hemorrhage 
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OUTCOME 
Table-2.23 Distribution of Outcome (N=100) 
 
Outcome Number Percentage 
Died 29 29 
Alive 71 71 
Total 100 100 
 
 
 
 
Figure  2.23 Distribution of outcome 
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Table-2.24 Distribution of Hyponatremia (N=100) 
 
Hyponatremia Number Percentage 
HN 43 43 
No HN 57 57 
Total 100 100 
 
 
 
 
Figure  2.24 Distribution of Hyponatremia 
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Table-2.25 Association of Hyponatremia with Outcome (N=100) 
 
Hyponatremia N 
Outcome 
P value* 
Died Alive 
HN 43 27 (62.7) 16 (37.3) 
<0.001 
No HN 57 13 (22.8) 44 (77.2) 
*Chi-squared test was used 
 
 
Figure  2.25 Association of Hyponatremia with outcome 
 
Statistical analysis of association of OUTCOME with Hyponatremia in ICH is 
SIGNIFICANT 
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From this statistical analysis it is found that there is significant 
association between hyponatremia at admission and in hospital mortality rate 
among patients presenting with spontaneous intracerebral haemorrhage. 
There is also significant association between following parameters with 
hyponatremia and mortality outcome in ICH patients. 
 Blood Pressure, 
 Serum Osmolality, 
 Urine Osmolality, 
 Serum Uric Acid , 
 Urinary Sodium Excretion. 
Admission Hyponatremia independently predicts mortality among the 
patients presenting with spontaneous intracerebral haemorrhage is inferred 
from our study. 
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DISCUSSION 
 A total of 100 cases were included in this study. Of these  
           30-39 years - 5 cases  
40-49 years - 13 cases  
50-59 years - 18 cases   
60-69 years - 27 cases 
70-79 years - 21 cases 
80-89 years - 15 cases 
 >  90 years - 1 case 
Age group of 50 to 80 years contribute majority of the study 
population.This is mainly attributed to the higher incidence of atherosclerosis 
in this age group. 
Males constitute about 64 cases and females 36 cases. 
The blood pressure was increased and uncontrolled in majority of the 
study population more in hyponatremia group.The increased blood pressure 
both systolic and diastolic component have deleterious effect on the outcome of 
patients with intracerebral haemorrhage.The mean systolic blood pressure was 
168.8 among the hyponatremic patients and was 158.1 among the 
normonatremic patients.The mean diastolic blood pressure was 100.7 among 
the hyponatremic patients and was 96.1 among the normonatremic patients. 
Elevated blood pressure is common acutely after ICH, even in patients without 
a prior history of HTN. In most cases, blood pressure spontaneously declines 
over 7 to 10 days, and the maximal decline occurs over the first 24 hours. 
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 In cohorts from Japan and the People's Republic of China according to 
usual diastolic BP (Eastern Stroke and Coronary Heart Disease Collaborative 
Research Group, 1998), logistic regression analyses showed a stronger 
association of usual diastolic BP with haemorrhagic stroke than with 
nonhaemorrhagic stroke. 
With regard to haemorrhagic stroke there is a mechanism of action plus 
evidence that blood pressure reduction can prevent the risk of stroke. It is well 
established that hematoma expansion in spontaneous ICH occurs within the 
first 24 hours after ictus in about one third of patients. Hematoma volume and 
hematoma expansion are predictors of 30-day functional outcome and 
mortality. A direct relationship between blood pressure and risk of hematoma 
enlargement has been shown in some studies, but others do not support this 
association. It is also unclear if high blood pressure is the cause or a 
hemodynamic response to the growing hematoma. 
 
The Systolic Hypertension in the Elderly Program (SHEP) Study 
determined the effects, on stroke, of treating isolated systolic hypertension in 
4736 elderly patients. Antihypertensive treatment appears to be more 
protective against haemorrhagic stroke than ischaemic stroke, the relative risk 
reduction for haemorrhagic stroke being 0.46 (95% CI: 0.21–1.02) compared 
to 0.63 (95% CI: 0.48–0.82) for ischaemic stroke. Treatment benefits were also 
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reported to appear earlier for haemorrhagic stroke compared to ischaemic 
stroke. 
High BP has also been shown to be an important risk factor for the 
recurrence of ICH. In a prospective study of 74 patients with hypertensive 
brain haemorrhage, higher diastolic BP was related to an increased rate of 
rebleeding.        
The recently reported Perindopril Protection Against Recurrent Stroke 
Study (PROGRESS) investigated the effects of BP lowering with an 
angiotensin-converting enzyme (ACE) inhibitor-based regimen in patients with 
a history of cerebrovascular disease. Compared with placebo, treatment with 
the ACE inhibitor, perindopril, with the addition of a diuretic, indapamide, in 
58% of subjects, resulted in a significant 28% (95% CI: 17–38) reduction in the 
occurrence of all stroke. Treatment appeared to offer greater protection against 
haemorrhagic stroke, reducing risk by 50% (95% CI: 26–67) compared to 
ischaemic stroke, which reduced risk by 24% (95% CI 10–35). The role of BP 
in the prognosis and major complications of acute ICH and optimal 
management of BP in the early stages of acute ICH is still unclear. 
The glasscow coma scoring used for assessing  the consciousness level 
in our study patients, does not have any significant association with 
hyponatremia and outcome. The mean GCS scoring among the hyponatremic 
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patients were 11.3.The mean GCS scoring among the normonatremic patients 
were 11.7. 
The Random blood sugar level of the study patients at time of 
admission, does not have any significant  association with hyponatremia and 
outcome. The mean Random blood sugar  among the study patients at the time 
of admission was between 100 to 200. 
The presence of multiple comorbid conditions like diabetes,coronary 
artery disease, bronchial asthma, chronic obstructive pulmonary disease, 
smoking, alcoholism among the study populations does not have any 
association with hyponatremia and outcome. 
Serum uric acid estimation has significant  association with 
hyponatremia and outcome among the study populations. Increased serum uric 
acid seen in CEREBRAL SALT WASTING [CSW] SYNDROME and 
Decreased serum uric acid seen in SYNDROME OF INAPPROPRIATE ANTI 
DIURETIC HORMONE [SIADH] SECRETION both happens in association 
with hyponatremia. Hence serum uric acid estimation among the hyponatremic 
patients is useful in differentiating the CEREBRAL SALT WASTING [CSW] 
SYNDROME from SYNDROME OF INAPPROPRIATE ANTI DIURETIC 
HORMONE [SIADH]. 
Serum osmolality estimation has significant  association with 
hyponatremia and outcome among the study populations.Decreased Serum 
osmolality seen both in CEREBRAL SALT WASTING[CSW] SYNDROME 
and Decreased serum uric acid seen in SYNDROME OF INAPPROPRIATE 
77 
 
ANTI DIURETIC HORMONE [SIADH] SECRETION has significant 
association  with hyponatremia and increases the in hospital mortality rate 
among the study patients. Hence, by correcting or maintaining the serum 
osmolality by mainly sodium correction will reduce the in hospital mortality 
rate among our study patients. 
Urine osmolality estimation has significant  association with 
hyponatremia and outcome among the study populations. Increased Urine 
osmolality seen both in CEREBRAL SALT WASTING[CSW] SYNDROME 
and in SYNDROME OF INAPPROPRIATE ANTI DIURETIC HORMONE 
[SIADH] SECRETION has significant association  with hyponatremia and 
increases the in hospital mortality rate among the study patients. Hence, by 
correcting or maintaining the Urine osmolality by mainly sodium correction or 
by drugs like vaptans, will reduce the in hospital mortality rate among our 
study patients. 
Urinary Sodium Excretion estimation has significant statistical 
association with hyponatremia and outcome among the study populations. 
Increased Urinary Sodium Excretion seen both in CEREBRAL SALT 
WASTING[CSW] SYNDROME and in SYNDROME OF INAPPROPRIATE 
ANTI DIURETIC HORMONE [SIADH] SECRETION has significant 
association  with hyponatremia and increases the in hospital mortality rate 
among the study patients. Hence, by correcting or preventing urinary sodium 
loss we can prevent hyponatremia and that will reduce the in hospital mortality 
rate among our study patients. 
78 
 
ECG findings seen among our study patients does not have any 
significant statistical association with hyponatremia and outcome. The common 
ECG findings seen among the study population were hypertensive changes in 
[21% ],Non specific changes of about [70%]. 
CT Brain Findings seen among our study patients does not have any 
significant statistical association with hyponatremia. However majority of the 
patients with Intracerebral Hemorrhage with midline shift and/or 
intraventricular extension were succumbed in our study population. The 
various CT Brain Findings noted among the study populations were 
1. Lobar Hemorrhage[27%] 
2. Infratentorial Hemorrhage[41%] 
3. Intracerebral Hemorrhage with Midline Shift[22%] 
4. Intracerebral Hemorrhage with Intraventricular Extension[10%] 
MRI Brain Findings seen among our study patients does not have any 
significant statistical association with hyponatremia. However majority of the 
patients with Intracerebral Hemorrhage with midline shift and/or 
intraventricular extension were succumbed in our study population. The 
various MRI Brain Findings noted among the study populations were 
1. Lobar Hemorrhage[27%] 
2. Infratentorial Hemorrhage[41%] 
3. Intracerebral Hemorrhage with Midline Shift[22%] 
4. Intracerebral Hemorrhage with Intraventricular Extension[10%] 
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 Among our study population of 100 patients with intracerebral 
haemorrhage, 
43 patients presented with hyponatremia,of which 27 patients [62.7%] died. 
The Non hyponatremic group [Either normonatremic or hypernatremic] 
contributes around 57 patients.Among them 13 patients [22..8%] were died. 
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SUMMARY 
 Hyponatremia in the setting of acute hemorrhagic stroke occurs in 35-40% 
patients which is of greater incidence in our study compared to the previous 
studies. 
 The prevalence is higher in males and among the middle aged. 
 Hyponatremia occurs more with Middle and Posterior cerebral arterial 
territories involvement. 
 SIADH has a higher prevalence than Cerebral Salt Wasting. 
 Hyponatremia and especially, cerebral salt wasting predisposes to a longer 
duration of hospital stay and poorer discharge disposition. 
 Hyponatremia at admission, is an independent predictor of short and long 
term mortality in stroke. 
 Cerebral Salt wasting has a poorer short term outcome than SIADH. 
 The following parameters have correlationship with occurrence of 
hyponatremia and inhospital  mortality among the  patients with hemorrhagic 
stroke.  
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CONCLUSIONS 
 INTRACEREBRAL HEMORRHAGE [ICH] is the second most common 
cause of stroke. 
 It accounts for about 10 to 15% of all strokes. 
 ICH has higher mortality risk with 30 day mortality of about 35-52%.Among 
this 40-45% death occurs within the first week of stroke attack. 
 Hypertension being the most common cause for ICH. 
 Most common symptoms being the headache followed by nausea,vomiting 
,altered sensorium,focal neurological deficit like weakness,numbness,speech 
disturbances , seizures, loss of consciousness,breathing difficulty.  
 Strict control of  blood pressure with lifestyle modifications,anti hypertensive 
drugs and health education can prevent or reduce the incidence of ICH. 
 Persistent and uncontrolled high blood pressure in acute ICH patients will lead 
to rebleeding in majority of the patients. 
 Hence acute lowering of blood pressure in acute ICH forms part of the 
treatment for INTRACEREBRAL HEMORRHAGE.   
 Hyponatremia is the most common electrolyte abnormality seen among the 
ICH patients. 
 As seen with other conditions,hyponatremia in ICH patients has deleterious  
effect on the outcome and prognosis of the patient. 
 ICH patients presenting with hyponatremia had greater incidence of inhospital 
mortality compared to ICH patients presenting with normal serum sodium 
level.   
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 ICH patients with hyponatremia had greater incidence of cerebral edema 
,seizures, increased intracranial pressure,hydrocephalous and also altered 
mentation which deleteriously affects the outcome of patients. 
 The most common causes of hyponatremia in ICH patients were  
1.SIADH [syndrome of inappropriate anti diuretic hormone secretion] 
2.CSW syndrome [cerebral salt wasting syndrome ] 
3.Excessive mannitol or other osmotic diuretic usage 
4.Excessive high ceiling diuretic usage 
 Whatever be the cause of hyponatremia,it should be diagnosed at the earliest 
and corrected in order to improve the outcome in ICH patients. 
 The following parameters have significant association with hyponatremia and 
outcome in patients with spontaneous ICH.  
1.Blood pressure 
2.Serum osmolality 
3.urine osmolality 
4.serum uric acid 
5.serum sodium level 
6.urinary sodium excretion 
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PROFORMA 
 
 Unsteadiness of gait 
 Deviation of angle of mouth 
DURATION OF SYMPTOMS                : 
H/o FEVER/ TRAUMA 
PAST HISTORY                                      : 
 Prior stroke 
 Diabetes mellitus 
 Hypertension 
 Cardiac disease 
 Epilepsy 
 Tuberculosis 
TREATMENT HISTORY                        :  
FAMILY HISTORY                                 :  
ADDICTIONS                                          : 
VITALS : Pulse  
                 Blood Pressure 
                 Respiratory Rate  
                 Temperature 
                 Daily input and output 
 
GENERAL EXAMINATION                  : 
 CENTRAL NERVOUS SYSTEM           : 
Higher Mental Functions                          : Consciousness 
                                                               Orientation 
                                                Speech 
 
Cranial Nerves    : 
 
Motor system      :  Bulk 
                                  Tone 
                        Power 
                        Reflexes 
Sensory system 
 
Cerebellar signs 
 
Meningeal signs 
 
GLASGOW COMA SCALE                    : E V M Total score : /15 
 
SYSTEMIC EXAMINATION                 : 
 
CARDIOVASCULAR SYSTEM            : 
Apex Beat 
Heart sounds 
Murmurs 
JVP 
 
RESPIRATORY SYSTEM                     : 
Breath sounds 
Added sounds 
Percussion 
Vocal Resonance 
 
 
GASTROINTESTINAL SYSTEM         : 
Any tenderness 
Liver span 
Shifting dullness 
   General Parameters 
 Complete hemogram 
 Peripheral Smear 
 Random Blood Sugar 
 Blood urea 
 Serum creatinine 
 ECG  
 Chest X-Ray 
 SPECIFIC PARAMETERS 
 CT scan Brain/ MRI Brain : 
 Serum sodium : 
 plasma Osmolality : Urine Sodium Serum Potassium Serum uric acid : Serum 
albumin : BUN/ Creatinine Hematocrit 
 Serum uric acid 
 Serum albumin Hematocrit 
 Serum potassium 
 
OUTCOME OF THE PATIENT: Death / Recovery and discharge 
 
  
åŠ¹î™ ð®õ‹ 
 
 
 
ªðò˜   :   
 
õò¶   :    
 
ð£Lù‹  : 
 
ºèõK  : 
 
 
 
 
 
 
 
«è£¬õ Üó² ñ¼ˆ¶õ‚ è™ÖK ñ¼ˆ¶õñ¬ùJ™ ñ¼.F.jPgj;Fkhh; î¬ô¬ñJ™ 
ï¬ìªðÁ‹ Þ‰î ÝŒM™ âù¶ º¿àì™ ñŸÁ‹ ÞóˆîŠ ðK«ê£î¬ù ªêŒ¶ ªè£œ÷ º¿ 
ñù¶ì¡ ê‹ñF‚A«ø¡. â¡¬ùŠ ðŸPò Mõóƒè¬÷ ð£¶è£Š¹ì¡ Þ‰î ÝŒM™ ªõOJì 
Ý†«êð¬í Þ™¬ô â¡Á ªîKMˆ¶‚ ªè£œA«ø¡. ï£¡ â‰î «ïóˆF½‹ ÝŒM™ Þ¼‰¶ 
Mô‚A‚ ªè£œÀ‹ àK¬ñ à‡´ â¡Á ÜP«õ¡. 
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KEY TO MASTER CHART 
GENDER 
1-MALE 
2-FEMALE 
RANDOM BLOOD SUGAR 
0- 70 TO 100 
1-100 TO 140 
2-140 TO 200 
3- >200 
COMORBIDITIES 
0 -NONE 
1- SHT 
2-DM 
3-BOTH 
SERUM OSMOLALITY 
0 -NORMAL 
1- DECREASED 
2-INCREASED 
URINE OSMOLALITY 
0 -NORMAL 
1- DECREASED 
2-INCREASED 
 
URINARY SODIUM EXCRETION 
0 -NORMAL 
1- DECREASED 
2-INCREASED 
PROTHROMBIN TIME 
1-WITH IN NORMAL RANGE 
ACTIVATED PARTIAL THROMBOPLASTIN TIME 
 1-WITH IN NORMAL RANGE 
INTERNATIONAL NORMLAISED RATIO 
1-WITH IN NORMAL RANGE 
ECG CHANGES 
1-Normal study 
2-Hypertensive Changes 
CT BRAIN FINDINGS 
1-Lobar Hemorrhage 
2-Infratentorial Hemorrhage 
3-Intra Cerebral Hemorrhage With Midline Shift 
4-Intra Cerebral Hemorrhage With Intraventricular Extension 
MRI BRAIN FINDINGS 
1-Lobar Hemorrhage 
2-Infratentorial Hemorrhage 
3-Intra Cerebral Hemorrhage With Midline Shift 
4-Intra Cerebral Hemorrhage With Intraventricular Extension 
OUTCOME 
1-Alive 
2-Died 
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1 Anthony raj 62 1 160/90 14 1 2 145 0 0 0 1 1 1 1 1 1 1 1
2 Muniyappan 58 1 150/100 13 1 0 142 0 1 1 1 1 1 1 1 0 0 1
3 Irudhayaraj 46 1 160/100 12 0 1 122 1 2 2 1 1 1 1 1 2 2 1
4 Yousuf 51 1 190/110 9 1 1 118 1 2 2 1 1 1 1 1 3 3 2
5 karrupusamy 77 1 170/90 12 2 3 141 0 0 0 1 1 1 1 2 2 2 1
6 kanniappan 35 1 160/90 14 0 0 144 0 0 0 1 1 1 1 1 1 1 1
7 Lakshmi 66 2 180/100 7 1 3 147 0 0 0 1 1 1 1 1 2 2 2
8 Rasathi 69 2 140/90 13 2 2 149 0 0 0 1 1 1 1 1 1 1 1
9 Zaheer 39 1 150/100 14 2 3 132 0 0 0 1 1 1 1 1 2 2 1
10 Palaniyammal 59 2 140/100 15 2 3 135 0 0 0 1 1 1 1 1 1 1 1
11 Parvathi 62 2 210/120 9 3 3 148 0 0 0 1 1 1 1 1 1 1 2
12 Paramasivam 67 1 160/100 14 3 2 136 0 0 0 1 1 1 1 2 0 0 1
13 Kuppusamy 53 1 140/900 13 1 0 127 1 2 2 1 1 1 1 2 0 0 1
14 Aarokkiya samy 59 1 150/90 13 2 0 136 0 0 0 1 1 1 1 2 1 1 1
15 Muthukannu 64 2 190/100 8 1 3 151 0 0 0 1 1 1 1 1 3 3 2
16 China thambi 65 1 180/100 7 2 3 114 1 2 2 1 1 1 1 1 3 3 2
17 Prabhu 59 1 160/90 12 0 1 139 0 1 1 1 1 1 1 2 2 2 1
18 Punitha 75 2 180/100 12 2 1 138 0 1 1 1 1 1 1 1 1 1 1
19 Marriyammal 44 2 200/110 9 2 1 112 1 2 2 1 1 1 1 1 2 2 2
20 Madheshwaran 49 1 140/90 14 1 0 132 0 0 0 1 1 1 1 1 1 1 1
21 Balasubramani 81 1 140/90 5 1 0 138 0 0 0 1 1 1 1 1 2 2 2
22 Ashokan 47 1 180/120 13 0 1 137 0 0 0 1 1 1 1 1 0 0 1
23 Ganeshan 67 1 210/120 11 3 3 138 0 0 0 1 1 1 1 1 1 1 1
24 Aanandhi 39 2 160/100 10 1 2 120 1 2 2 1 1 1 1 2 0 0 2
25 Akilandeshwari 77 2 180/120 12 2 3 130 1 2 2 1 1 1 1 1 1 1 1
26 Amudhan 66 1 190/110 12 0 1 134 0 0 0 1 1 1 1 1 0 0 1
27 Pushpavalli 58 2 160/90 12 1 2 142 0 0 0 1 1 1 1 1 0 0 1
28 Manimegalai 51 2 180/110 12 1 1 141 0 0 0 1 1 1 1 1 0 0 1
29 Marimuthu 61 1 150/90 9 1 0 121 1 2 2 1 1 1 1 1 2 2 2
30 Durairaj 76 1 160/90 13 2 2 144 0 0 0 1 1 1 1 1 1 1 1
31 Narayanasamy 68 1 150/100 14 1 2 145 0 0 0 1 1 1 1 1 1 1 1
32 Annamalai 78 1 200/100 15 1 3 136 0 0 0 1 1 1 1 1 2 2 1
33 Chidhambaram 68 1 210/120 11 1 3 114 1 2 2 1 1 1 1 2 3 3 2
34 Velammal 72 2 150/90 13 1 0 138 0 0 0 1 1 1 1 2 1 1 1
35 Rajan 61 1 160/90 12 2 2 128 1 2 2 1 1 1 1 2 0 0 2
36 Arivazhagan 73 1 190/110 12 2 1 139 0 0 0 1 1 1 1 1 0 0 1
37 Thiyagarajan 80 1 160/100 10 3 2 107 1 2 2 1 1 1 1 1 3 3 2
38 Pothum ponnu 79 2 160/90 10 3 2 137 0 0 0 1 1 1 1 1 2 2 1
39 Fathima 77 2 210/100 11 1 3 142 0 0 0 1 1 1 1 1 1 2 2
40 Saraswathi 84 2 180/100 11 1 3 134 0 1 1 1 1 1 1 1 2 2 1
41 Janani 86 2 190/100 12 2 3 131 1 2 2 1 1 1 1 1 1 1 2
42 Raghuvaran 39 1 150/100 13 3 2 144 0 0 0 1 1 1 1 1 2 2 1
43 Aravindhan 73 1 200/110 9 0 1 149 0 0 0 1 1 1 1 1 1 1 2
44 Swaminathan 57 1 210/120 12 0 1 129 1 2 2 1 1 1 1 1 1 1 2
45 Manoharan 68 1 140/90 12 1 0 148 0 1 1 1 1 1 1 1 2 2 1
46 Adithyan 74 1 150/90 14 2 2 126 1 2 2 1 1 1 1 2 0 0 2
47 Ramarajan 85 1 160/100 11 3 2 145 0 0 0 1 1 1 1 2 0 0 1
48 Kumaravel 82 1 190/110 13 1 3 130 1 2 2 1 1 1 1 1 1 1 1
49 Loganayagi 91 2 150/90 12 1 3 146 0 0 0 1 1 1 1 2 1 1 1
50 Mylathal 44 2 160/100 11 3 2 138 0 0 0 1 1 1 1 1 3 3 2
51 Immanuvel 48 1 130/100 14 3 3 144 0 1 1 1 1 1 1 1 0 0 1
52 Ilavarasan 59 1 190/120 12 2 1 121 1 2 2 1 1 1 1 1 2 2 2
53 Govindammal 67 2 150/100 6 1 1 119 1 2 2 1 1 1 1 2 2 2 2
54 Raman 46 1 140/90 14 2 2 128 1 2 2 1 1 1 1 1 1 1 1
55 Babu 80 1 130/80 13 0 0 146 0 1 1 1 1 1 1 1 1 1 1
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56 Bagiyavathi 55 2 130/90 12 1 2 136 0 0 0 1 1 1 1 2 1 1 1
57 Seeniyammal 49 2 170/100 5 2 3 140 0 0 0 1 1 1 1 1 2 2 2
58 Sivagami 81 2 140/990 11 2 2 139 0 0 0 1 1 1 1 1 0 0 1
59 Gurusamy 69 1 130/90 8 1 0 119 1 2 2 1 1 1 1 2 1 1 2
60 Raja gopal 67 1 200/120 11 2 3 133 0 0 0 1 1 1 1 1 0 0 1
61 Santhanam 72 1 180/110 12 2 3 134 0 0 0 1 1 1 1 1 0 0 1
62 Suriya kumar 61 1 160/100 13 0 1 133 0 0 0 1 1 1 1 2 1 1 2
63 Kumara guru 66 1 150/100 10 3 2 145 0 0 0 1 1 1 1 1 3 3 2
64 Manonmani 63 2 190/120 14 2 1 138 0 0 0 1 1 1 1 1 1 1 1
65 Malathi 72 2 200/110 11 3 3 106 1 2 2 1 1 1 1 1 3 3 2
66 Mahendran 81 1 130/90 14 1 0 141 0 0 0 1 1 1 1 1 1 1 1
67 Deenadayalan 56 1 160/90 9 1 2 116 1 2 2 1 1 1 1 1 2 2 2
68 Marget 58 2 140/90 13 0 0 142 0 0 0 1 1 1 1 2 1 1 1
69 Merlin 85 2 180/90 12 1 1 146 0 0 0 1 1 1 1 1 1 1 1
70 Jaithun beevi 74 2 170/110 8 2 3 144 0 0 0 1 1 1 1 1 1 1 2
71 Sarbudeen 47 1 140/90 12 3 2 139 0 0 0 1 1 1 1 1 2 2 1
72 Farooq 64 1 130/90 12 2 2 124 1 2 2 1 1 1 1 1 0 0 1
73 Saravanan 48 1 160/100 13 2 3 128 1 2 2 1 1 1 1 1 0 0 2
74 Savithri 82 2 140/90 12 3 2 130 1 2 2 1 1 1 1 1 0 0 2
75 Vijay 76 1 140/100 11 1 0 115 1 2 2 1 1 1 1 2 1 1 2
76 Mohan 67 1 130/90 12 2 0 136 0 0 0 1 1 1 1 1 1 1 1
77 Velusamy 63 1 150/100 7 0 0 138 0 0 0 1 1 1 1 1 2 2 2
78 Vellaiammal 56 2 210/110 9 0 3 106 1 2 2 1 1 1 1 2 3 3 2
79 Madhana gopal 58 1 180/100 11 1 1 132 1 2 2 1 1 1 1 1 1 1 1
80 Krishna samy 75 1 150/90 12 0 2 130 1 2 2 1 1 1 1 2 1 1 2
81 Helen rose mary 51 2 160/90 13 1 1 128 1 2 2 1 1 1 1 1 0 0 2
82 Joseph raj 46 1 170/90 13 2 3 134 0 0 0 1 1 1 1 1 0 0 1
83 Aarumugam 49 1 130/80 13 1 0 137 0 0 0 1 1 1 1 1 0 0 1
84 Boopalan 84 1 160/100 8 1 3 149 0 0 0 1 1 1 1 1 2 2 2
85 Krishna moorthy 71 1 140/90 12 1 2 124 1 2 2 1 1 1 1 1 1 1 2
86 Kamalraj 55 1 140/90 14 3 2 144 0 0 0 1 1 1 1 1 1 1 1
87 Uma devi 68 2 130/80 15 0 0 147 0 0 0 1 1 1 1 1 0 0 1
88 Eshwari 76 2 120/80 14 2 0 138 0 0 0 1 1 1 1 1 1 1 1
89 Jameela banu 81 2 180/90 13 1 1 129 1 2 2 1 1 1 1 1 0 0 2
90 Sebasthiammal 74 2 210/120 10 3 3 133 0 1 1 1 1 1 1 1 0 0 1
91 Sivakumaran 49 1 190/100 11 2 3 134 0 0 0 1 1 1 1 1 1 1 1
92 Usha devi 43 2 160/100 10 2 1 150 0 0 0 1 1 1 1 1 3 3 2
93 Raveendhran 38 1 160/100 14 1 1 139 0 1 1 1 1 1 1 1 1 1 1
94 Muruganandham 83 1 150/90 12 0 1 138 0 0 0 1 1 1 1 1 0 0 1
95 Shenbagavalli 79 2 160/100 9 2 1 107 1 2 2 1 1 1 1 1 2 2 2
96 Ponmudi 69 1 150/90 10 0 3 142 0 0 0 1 1 1 1 1 1 1 1
97 Kannappan 77 1 130/90 12 2 2 145 0 0 0 1 1 1 1 1 1 1 1
98 Santhana devan 63 1 140/90 11 2 0 114 1 2 2 1 1 1 1 2 2 2 2
99 Sankaran 80 1 180/100 10 3 3 142 0 0 0 1 1 1 1 1 1 1 1
100 Nandhakumaran 52 1 120/80 13 1 0 135 0 0 0 1 1 1 1 1 0 0 1
